APTEEUS

📍 Lille, France🗓 Founded 2013👥 5 employees💰 Last funded Jan 2023
APTEΞUS was created to provide clinicians and their patients suffering from orphan diseases, an innovative service of clinical biology that perfectly meets the emerging challenge of individualized medicine. APTEΞUS is engaged in patient-centric discovery of individualized treatments. Our technology allows the testing of thousands of molecules directly on primary cells sampled from patient with inborn error of metabolism. We can rapidly identify molecules that specifically correct the very molecular defect of the patient and give him a new opportunity to be cured.
1
Total investors
0
Early stage
0
Mid stage
1
Late stage
2013
Founded
Investor geography1 country
France
1
Frequently asked questions
Who invested in APTEEUS?
APTEEUS has 1 investors on record on gritt.io and 1 late-stage investors.
When did APTEEUS last raise funding?
The most recent investment in APTEEUS recorded on gritt.io was in January 2023.
When was APTEEUS founded?
APTEEUS was founded in 2013.
What industry is APTEEUS in?
APTEEUS operates in Biotechnology Research. Find similar Biotechnology Research investors on gritt.io.
Where is APTEEUS based?
APTEEUS is headquartered in Lille, France.